Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 187 followers
Last updated about 14 hours ago
about 14 hours ago
Basel, 18 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
2 days ago
Roche will publish its Half Year Results of 2025 prior to the...
23 days ago
Roche will publish its Half Year Results of 2025 prior to the...
26 days ago
Positive phase I/II data presented at the 2025 International Society on Thrombosis...
29 days ago
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival...
about 1 month ago
We are pleased to invite investors and analysts to participate in our...
about 1 month ago
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical...
about 1 month ago
After a thorough clinical review, the benefit-risk for the use of Elevidys...
about 2 months ago
46% reduction in the risk of disease progression or death, and 27%...
about 2 months ago
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than...
about 2 months ago
Patients on fenebrutinib had low relapse rates with data showing no active...
about 2 months ago
We are pleased to invite investors and analysts to participate in our...